Company / Current Liabilities per Share
Arrowhead Pharmaceuticals Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.57
FY2025
5-year range
$0.96 / $1.57
FY2021-FY2025
Trend
+63.5%
vs FY2024
Sector context
#80 of 210
Health Care
What the data says
At $1.57, Arrowhead Pharmaceuticals's current liabilities per share ranks #131 of 210 in the Health Care sector. Current Liabilities per Share returned to growth in FY2025 after 3 years of decline, reaching $1.57.
Based on SEC 10-K filings.
1.57 in FY2025 with a 5-year CAGR of +29.8%.
Increased from $1.00 to $1.57 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +5.7%
- 5-Year CAGR
- +29.8%
- 10-Year CAGR
- -
Sector benchmark
#131 of 210 in Health CareTop 62% of 210This company $1.57 Sector average $23.79
▼
-93.4% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 63.5% year-over-year.
- Ranks #80 out of 210 companies in the Health Care sector.
- Lowest current liabilities per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.57 | +63.5% |
| FY2024 | $0.96 | -3.4% |
| FY2023 | $1.00 | -25.2% |
| FY2022 | $1.33 | -7.0% |
| FY2021 | $1.43 | +236.0% |
| FY2020 | $0.43 | -61.2% |
| FY2019 | $1.10 | +563.4% |
| FY2018 | $0.17 | -38.3% |
| FY2017 | $0.27 | -37.7% |
| FY2016 | $0.43 | +48.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026